Drug General Information
Drug ID
D08UKF
Former ID
DNC006024
Drug Name
N-(3,5-dimethoxyphenethyl)docos-13-enamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527788]
Structure
Download
2D MOL

3D MOL

Formula
C32H55NO3
Canonical SMILES
CCCCCCCCC=CCCCCCCCCCCCC(=O)NCCC1=CC(=CC(=C1)OC)OC
InChI
1S/C32H55NO3/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-32(34)33-25-24-29-26-30(35-2)28-31(27-29)36-3/h11-12,26-28H,4-10,13-25H2,1-3H3,(H,33,34)/b12-11-
InChIKey
WGUQNXILGCVNIV-QXMHVHEDSA-N
PubChem Compound ID
Target and Pathway
Target(s) Cannabinoid receptor 1 Target Info Inhibitor [527788]
KEGG Pathway Rap1 signaling pathway
Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signaling
PANTHER Pathway Endogenous cannabinoid signaling
Pathway Interaction Database N-cadherin signaling events
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
BDNF signaling pathway
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 527788Bioorg Med Chem Lett. 2006 Jan 1;16(1):138-41. Epub 2005 Oct 6.New metabolically stable fatty acid amide ligands of cannabinoid receptors: Synthesis and receptor affinity studies.
Ref 527788Bioorg Med Chem Lett. 2006 Jan 1;16(1):138-41. Epub 2005 Oct 6.New metabolically stable fatty acid amide ligands of cannabinoid receptors: Synthesis and receptor affinity studies.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.